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Abstract In 2007, the International Knockout Mouse
Consortium (IKMC) made the ambitious promise to gen-
erate mutations in virtually every protein-coding gene of
the mouse genome in a concerted worldwide action. Now,
5 years later, the IKMC members have developed high-
throughput gene trapping and, in particular, gene-targeting
pipelines and generated more than 17,400 mutant murine
embryonic stem (ES) cell clones and more than 1,700
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mutant mouse strains, most of them conditional. A com-
mon IKMC web portal (www.knockoutmouse.org) has
been established, allowing easy access to this unparalleled
biological resource. The IKMC materials considerably
enhance functional gene annotation of the mammalian
genome and will have a major impact on future biomedical
research.
Introduction
Annotation of the human and mouse genomes has identi-
fied more than 20,000 protein-coding genes and more than
3,000 noncoding RNA genes. Together, these genes
orchestrate the development and function of the organism
from fertilization through embryogenesis to adult life.
Despite the dramatic increase in knowledge of variation in
human genomes of healthy and diseased individuals, the
normal functions of common forms of most genes are still
unknown and consequently the disease significance of rare
variants remains obscure as well.
To determine gene function, mutation of those genes is
required in model organisms. The mouse has long been
regarded as ideal for this purpose. Conservation of most
aspects of mammalian development, anatomy, metabolism,
and physiology between humans and mice is underscored
by strong one-to-one orthologous relationships between
genes of the two species. Conservation of gene function is
strongly supported by similar phenotypic consequences of
complete or partial loss-of-function mutations in ortholo-
gous genes in both species and by functional replaceability
of mouse genes by their human counterparts (Wallace et al.
2007).
To provide a platform for addressing vertebrate gene
function on a large scale, the research community came
together to establish a genome-wide genetic resource of
mouse mutants (Austin et al. 2004; Auwerx et al. 2004). The
consensus was that the future currency of this biological
resource should be based on ES cells, which can be readily
transferred between laboratories and across international
boundaries. It was also felt that the most desirable alleles
would be those generated by gene targeting. Bespoke designs
for each gene would accommodate each gene’s unique
structural attributes and take account of adjacent genomic
features. Uncertainty in the scalability of gene-targeting
technology coupled with the availability of several gene-trap
libraries and the speed with which additional mutant alleles
could be generated by gene-trapping methods resulted in
agreement that the resource should be generated initially by
using both gene-targeting and gene-trapping technologies.
Thus, the vision emerged of a core public archive of ES
cell clones on a single uniform genetic background, each
clone carrying an engineered mutation in a different gene.
To extract biological insights from this resource, individual
ES cell clones would be converted into mice by individual
investigators and organized programs.
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To deliver the ES cell resource toward this vision of
functional annotation, four international programs in Eur-
ope and North America were established with the goal of
achieving saturation mutagenesis of the mouse genome:
EUCOMM, KOMP, NorCOMM, and TIGM (see Table 3).
These programs were the founding members of the Inter-
national Knockout Mouse Consortium (IKMC), fostering
groups to work together in a highly coordinated, stan-
dardized manner, to share technologies, to maximize out-
put, and to largely avoid duplication of effort (Collins et al.
2007). The IKMC consortium has generated mainly con-
ditional but also constitutive mutations, with the former
class of mutations facilitating tissue-specific assessment of
gene function at desired time points, especially in situa-
tions where an essential requirement of a gene product in
one context can exclude analysis in another.
IKMC technology
The IKMC mutant ES cell resources have been developed
for the most part in a C57BL/6N genetic background using
cell lines that have achieved clonal germline transmission
rates of up to 80 % (Pettitt et al. 2009). Mutations were
generated initially by using both gene-trapping and gene-
targeting technologies. However, the greater utility and
desirability of targeted alleles, designed and generated with
nucleotide precision, led to phasing out of gene trapping as
the efficiency of the high-throughput gene-targeting pipe-
lines became established. Progressive improvements in
mouse genome annotation, computational targeting vector
design, and 96-well recombineering protocols as well as
high efficiencies of gene targeting have facilitated the rapid
construction of targeted ES cell clones at unprecedented
rates (Skarnes et al. 2011).
The alleles generated by IKMC members are lacZ tag-
ged and are either null/conditional or null/deletion alleles
(Fig. 1). The largest category of targeted clones in the
resource contains an allele design known as ‘‘knockout-
first’’ from which conditional alleles can be established
following exposure to a site-specific recombinase. A con-
ditional allele is created by the deletion of a critical exon
which is flanked by loxP sites. Critical exons are those that
(1) when deleted, shift the reading frame, (2) are common
to all known isoforms, and (3) are contained in the first
50 % of the coding region. Conditional alleles are also
amenable to further modification by recombinase-mediated
cassette exchange (RMCE), which can be used to insert
other coding sequences into these alleles (Osterwalder et al.
2010; Schnu¨tgen et al. 2011). The other major class of
mutations in the resource comprises lacZ-tagged nulls,
constructed as large deletions that are not amenable to
further modification (Valenzuela et al. 2003).
IKMC ES cell and mouse resources
Currently, the IKMC ES cell resource contains targeted and
trapped alleles for 17,473 unique protein-coding genes.
The targeted ES cell resource contains mutations in 13,840
unique genes of which 10,100 are null/conditional. The ES
cell gene-trap resource contains mutations in 11,539 unique
genes of which 4,414 are conditional (Table 1,
www.knockoutmouse.org). Due to the random nature of
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gene trapping, there is some overlap and redundancy
between the resources. In general, the IKMC has generated
a median of four independent clones per gene. This
redundancy not only helps to assure germline transmission
but also provides significant allelic diversity (e.g., condi-
tional or nonconditional alleles, different insertion sites,
and vector designs). The use of 129 Sv ES cells early in the
project for the gene-trap resource also provides the option
of studying mutations in the same gene in two different
genetic backgrounds for 4,600 genes in the resource.
The process of converting IKMC ES cell resources into
mice was initiated alongside the gene-targeting and -trap-
ping pipelines as a systematic quality control measure and
also for phenotyping purposes. So far, 1,709 mutant mouse
lines have been established by all the IKMC members
(Table 1). Generation of mice at scale in addition has taken
place in organized efforts in a few centers, coupled with
systematic phenotyping programs such as the EC-sup-
ported EUMODIC Project and the Wellcome Trust Sanger
Institute’s Mouse Genetics Programme (MGP) (Table 3).
As of July 2012, from both projects’ databases, i.e., www.euro
phenome.org and www.sanger.ac.uk/mouseportal, already
919 targeted lines can be identified that have been pheno-
typically examined. Of these, 652 have an annotated
phenotype.
IKMC repositories and distribution
Repositories have an essential function to secure and
maintain the investment in the resource for future genera-
tions of scientists. Repositories have the obligation to
ensure and preserve the quality of the resource and to act as
honest brokers with efficient, unrestricted, and unencum-
bered distribution to third-party users.
The distribution of IKMC vectors and ES cells takes
place through several repositories in Europe, the US, and
Canada (EuMMCR, KOMP, TIGM, and CMMR, Tables 2,
3). The repositories conduct stringent quality control on
the vectors and ES cell clones prior to distribution to
ensure the integrity of each allele. They currently distribute
nonoverlapping sectors of the IKMC resource to a global
user group. Altogether, these centers have already
Fig. 1 Vectors used by the
IKMC: targeting vectors:
a EUCOMM/KOMP-CSD
knockout-first allele; b KOMP-
Regeneron null allele generating
large deletions; c NorCOMM
promoter-driven targeting
vector. Most commonly used
trapping vectors: d conditional
EUCOMM vector
rsFlipROSAbgeo*; e TIGM
vector VICTR76; f NorCOMM
vector UPA
Table 1 IKMC progress (as of February 2012)
Total genes KOMP EUCOMM NorCOMM TIGM
CSD Regeneron
Targeting
vectors
6,577 5,905 8,379 916 –
Targeted
ES cells
5,244 4,196 6,887 609 –
Trapped ES
cells
4,414 3,595 9,390
Mutant
mice
409 359 647 42 252
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distributed 1,029 targeting vectors and 4,126 mutant ES
cell alleles.
The IKMC mice are distributed through EMMA,
MMRRC/KOMP, TIGM, and CMMR, the European, US,
and Canadian mouse repositories, respectively (Tables 2,
3). To date, of the 1,709 mutated mouse lines, 1,107 (65 %)
have been distributed outside of the center in which they
were initially produced (Table 2). The dominant impact of
IKMC resources on the activity of these repositories is
already apparent, e.g., more than 50 % of mice distributed
by EMMA were derived from IKMC resources. IKMC
mice are also being generated and analyzed in distributed
activities by hundreds of individual specialist laboratories
worldwide, which to date have cumulatively received
4,126 mutant ES cell alleles from the repositories.
In summary, to date already 6,262 mutant alleles have
been distributed worldwide as vectors, ES cells, or mice
(about 35 % of IKMC alleles available), and the interna-
tional requests are still increasing.
IKMC web portal
The integrated, public IKMC web portal (http://www.
knockoutmouse.org) summarizes the IKMC progress and
enables researchers to obtain IKMC genetic resources from
designated repositories. It links to IKMC members’ web
pages and to related genetic resources such as those
available from the International Gene Trap Consortium
(IGTC) and the International Mouse Strain Resource
(IMSR) (Table 3) (Ringwald et al. 2011). The IKMC
alleles are displayed on the Ensembl and UCSC genome
browsers with standardized allele identification registered
in Mouse Genome Informatics (MGI, www.informatics.
jax.org) database.
The IKMC web portal supports use of the genetic
resources through provision of detailed molecular struc-
tures of mutant alleles. Researchers may nominate genes of
interest for prioritization if targeted mutations are not yet
available, although the current coverage of 87 % of the
protein-coding genes provides a high chance that a useful
allele has already been generated.
IKMC and beyond
The IKMC ES cell resource was envisaged as an essential
stepping stone required for the efficient generation of
mouse mutants at scale. This resource is nearing comple-
tion and is already being accessed by novel large-scale
programs to generate mice for phenotypic analysis. An
organized effort, the International Mouse Phenotyping
Consortium (IMPC), has just been launched (Table 3).
Many centers worldwide will contribute to this effort,
ultimately generating and analyzing more than 15,000
mouse mutants based on the IKMC resource over the next
decade, establishing what will constitute a functional
Encyclopedia of the Mammalian Genome.
The IKMC resource, although very comprehensive, still
remains incomplete. Ongoing efforts, performed mainly by
the EUCOMMTools project (Table 3), will improve gen-
ome coverage and the quality of the mutant alleles in the
resource over the next 3 years. This will include replacing
gene-trap alleles with targeted ones and generating condi-
tional alleles when only a null allele is available. The
resource will also continue to expand to cover other classes
of genes such as noncoding RNAs.
The IKMC resource includes both vectors and ES cells
that can be further modified by RMCE to insert different
coding sequences into any conditional mutant IKMC allele
such as reporter genes, recombinases, and human orthologs
or, e.g., an allele’s missense mutations. In an era in which
an extraordinary amount of human variation sequence is
becoming available, functional assessment of variants will
require analysis under physiological levels of expression
and regulation, most reliably achieved by insertion into the
mouse orthologous locus.
The examination of a null allele is the requisite first step
in order to establish the ground state (null phenotype) of
any gene function in the genome. Subsequently, it is
desirable to conduct more focused analysis by controlling
the generation of the mutation temporally and spatially.
The conditional sector of the resource is designed for use
with the recombinase Cre, for which a number of trans-
genic mouse lines are available. The number and charac-
terization level of these lines will increase with various
initiatives currently underway [like EUCOMMTools,
CanEuCre, and the NorCOMM successor project Nor-
COMM2LS (Table 3)], and will eventually cover the
majority of embryonic and adult tissues and cell types.
Phenotypic analysis of mutant mouse lines generated
from IKMC resources enables a better understanding of
complex biology such as whole organism physiology,
Table 2 IKMC reagents distributed (as of February 2012)
Type of
material
KOMP EuMMCR/
EMMA
CMMR TIGM
Targeting
vectors
677 346 6 –
Mutant ES
cell clones
(alleles)
3,798 (1,345) 5,041 (1,867) 520 (311) 603 (603)
Mutant mice
(alleles)
430 (310) 600 (530) 19 (15) 252 (252)
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behavior, and adult tissue integrity. In addition, biological
insights can also be gained from analysis of cellular phe-
notypes in culture. IKMC resources facilitate the genera-
tion of homozygous mutant ES cells by retargeting the
second allele in vitro.
Genetic manipulation of mouse ES cells has reached
such a degree of efficiency and sophistication that ES cells
can be generated with virtually any genetic change. The
success of these technologies provides the groundwork for
extension to other mammalian species such as rat, and to
human ES and induced pluripotent stem (iPS) cells.
Acknowledgments The authors thank the European Commission
(EC, LSHG-CT-2005-018931, Health-F4-2010-261492), the National
Institutes of Health (NIH), Genome Canada, and the State of Texas
for funding.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS,
Dove WF, Duyk G, Dymecki S, Eppig JT et al (2004) The
knockout mouse project. Nat Genet 36:921–924
Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M,
Berns A, Bradley A, Brown S, Carmeliet P et al (2004) The
European dimension for the mouse genome mutagenesis pro-
gram. Nat Genet 36:925–927
Collins FS, Rossant J, Wurst W (2007) A mouse for all reasons. Cell
128:9–13
Osterwalder M, Galli A, Rosen B, Skarnes WC, Zeller R, Lopez-Rios
J (2010) Dual RMCE for efficient re-engineering of mouse
mutant alleles. Nat Methods 7:893–895
Pettitt SJ, Liang Q, Rairdan XY, Moran JL, Prosser HM, Beier DR,
Lloyd KC, Bradley A, Skarnes WC (2009) Agouti C57BL/6N
embryonic stem cells for mouse genetic resources. Nat Methods
6:493–495
Ringwald M, Iyer V, Mason JC, Stone KR, Tadepally HD, Kadin JA,
Bult CJ, Eppig JT, Oakley DJ, Briois S et al (2011) The IKMC
web portal: a central point of entry to data and resources from the
International Knockout Mouse Consortium. Nucleic Acids Res
39:D849–D855
Schnu¨tgen F, Ehrmann F, Poser I, Hubner NC, Hansen J, Floss T,
deVries I, Wurst W, Hyman A, Mann M, von Melchner H (2011)
Resources for proteomics in mouse embryonic stem cells. Nat
Methods 8:103–104
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V,
Mujica AO, Thomas M, Harrow J, Cox T et al (2011) A
conditional knockout resource for genome-wide analysis of
mouse gene function. Nature 474:337–342
Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Econonomides
AN, Auerbach W, Poueymirou WT, Adams NC, Rojas J,
Yasenchak J et al (2003) High-throughput engineering of the
mouse genome coupled with high-resolution expression analysis.
Nat Biotechnol 21:652–659
Wallace HAC, Marques-Kranc F, Richardson M, Luna-Crespo F,
Sharpe JA, Hughes J, Wood WG, Higgs DR, Smith AJH (2007)
Manipulating the mouse genome to engineer precise functional
syntenic replacements with human sequence. Cell 128:197–209
586 A. Bradley et al.: IKMC: mammalian gene function resource
123
